JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111412200 on March 8, 2002

J. Biol. Chem., Vol. 277, Issue 22, 19889-19896, May 31, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/22/19889    most recent
M111412200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, Y.
Right arrow Articles by McKnight, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Y.
Right arrow Articles by McKnight, G. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Kinase A Deficiency Causes Axially Localized Neural Tube Defects in Mice*

Yongzhao Huang, Henk Roelink, and G. Stanley McKnightDagger

From the Department of Pharmacology and Department of Biological Structure, University of Washington School of Medicine, Seattle, Washington 98195

Received for publication, November 29, 2001, and in revised form, February 20, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We have studied the function of protein kinase A (PKA) during embryonic development using a PKA-deficient mouse that retains only one functional catalytic subunit allele, either Calpha or Cbeta , of PKA. The reduced PKA activity results in neural tube defects that are specifically localized posterior to the forelimb buds and lead to spina bifida. The affected neural tube has closed appropriately but exhibits an enlarged lumen and abnormal neuroepithelium. Decreased PKA activity causes dorsal expansion of Sonic hedgehog signal response in the thoracic to sacral regions correlating with the regions of morphological abnormalities. Other regions of the neural tube appear normal. The regional sensitivity to changes in PKA activity indicates that downstream signaling pathways differ along the anterior-posterior axis and suggests a functional role for PKA activation in neural tube development.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Many studies have demonstrated roles for protein kinase A (PKA)1 in the regulation of postnatal physiology, but limited knowledge has been gained on the function of PKA in mammalian development. Earlier studies have suggested potential requirements for PKA activity in regulating oocyte maturation in vertebrates (1, 2) and in activating the zygotic genome in preimplantation mouse embryos (3).

Probably the most striking role of PKA in embryonic development is its negative regulation of the Hedgehog (Hh) signaling pathway. Lack of PKA activity leads to ectopic expression of Hh target genes in Drosophila imaginal discs (4). Manipulation of PKA activity in vertebrates has also suggested that the negative regulation of the Sonic hedgehog (Shh) signaling pathway is conserved (5-8). Shh signaling has been implicated in diverse processes in vertebrate development including cartilage differentiation, myotome and sclerotome specification, limb morphogenesis, and the specification of different neuronal cell types along the dorsoventral axis of the neural tube (9, 10). Whether PKA is involved in all of these processes and how PKA functions as a negative regulator (directly in the Hedgehog pathway or in a parallel pathway) are unclear.

There are two catalytic (Calpha and Cbeta ) and four regulatory (RIalpha , RIbeta , RIIalpha , and RIIbeta ) subunit genes of PKA identified in mice (11). These regulatory and catalytic subunits assemble into a heterotetramer composed of two C and two R subunits, and this PKA holoenzyme dissociates to release active C subunit when cAMP binds to the R subunits. Although each of the regulatory subunit genes encodes a single protein isoform, the catalytic subunit genes encode multiple variants. The Calpha gene encodes two variants, Calpha 1 and Calpha 2, from two distinct promoters. In adult mice, Calpha 1 is expressed ubiquitously, whereas Calpha 2 is testis-specific (12). The Cbeta gene produces three splice variants, Cbeta 1, Cbeta 2, and Cbeta 3. Although Cbeta 1 is found in all tissues examined, Cbeta 2 and Cbeta 3 are brain-specific (13). The expression pattern of PKA isoforms have also been examined by in situ hybridization in mouse embryos at late organogenesis stage, showing an expression pattern similar to that in adult mice (14).

All studies on the roles of PKA in vertebrate development have utilized transgenic or pharmacological manipulations, which have limitations in their ability to mimic the spatial and temporal patterns of endogenous activity of PKA. One way to solve this problem is to use PKA knockout mice, and we have created null mutations in each of the four regulatory and two catalytic subunits of PKA expressed in the mouse. The only single knockout to show developmental abnormalities is the RIalpha regulatory subunit null mutation. The RIalpha knockout mouse dies during embryonic development because of a severe defect in mesoderm formation resulting from an increase in basal PKA activity.2

The present study reports developmental consequences of decreased PKA activity in mice. A PKA-deficient mouse was generated with only one functional catalytic subunit allele, either Calpha or Cbeta , of PKA. The mutant mice with reduced PKA activity developed localized neural tube defects (NTDs). The spinal neural tube defect occurred at the thoracic to sacral regions of the neural tube, was 100% penetrant, and could lead to spina bifida in newborn mice, whereas exencephaly (open cranial neural tube) was partially penetrant and only present in mice with a single Cbeta allele remaining. Histological examination of the abnormal spinal neural tube revealed a closed neural tube with an enlarged lumen and abnormal neuroepithelium. Marker analysis showed dorsal expansion of Shh-dependent cell types, resulting in a ventralized neuronal identity in the affected neural tube. Decreasing PKA activity also resulted in an increase in apoptotic cell death in the abnormal neuroepithelium and dorsal root ganglia, suggesting that PKA activity plays an anti-apoptotic role in the developing neural tube. All of the defects were observed in the posterior neural tube from the thoracic to sacral regions, whereas the cervical neural tube appeared normal, suggesting differential dependence on PKA activity along the anterior-posterior axis.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Animals-- The Calpha and Cbeta 1 knockout mice were generated as previously described (15, 16). Calpha +/-Cbeta 1+/- heterozygous mice were maintained on a 129/C57BL6 mixed background. Genotyping of both Calpha and Cbeta alleles was performed on tail DNA by PCR analysis. The wild type Calpha allele was detected by a pair of primers (CTGACCTTTGAGTATCTGCAC and GTCCCACACAAGGTCCAAGTA), which amplify a 250-nucleotide fragment of the intron between exons 6 and 7. The Calpha knockout allele was detected by another pair of primers (GTGGTTTGTCCAAACTCATCAATGT and AGACTACTGCTCTATCACTGA), which amplify a 270-nucleotide fragment of the region between the 3' end of the neomycin resistance gene and a portion of the intron just 3' to exon 8. Genotyping of the Cbeta wild type allele was performed using the primers Cbeta PCR-1B (CCGTCATCCCTGCTTGCGGA) and Cbeta PCR 2 (CTCCACTTCGCTGCCTTTCT), which amplify a 69-nucleotide fragment in the first exon. The knockout Cbeta 1 allele was detected using the primers Cbeta PCR-1B and Cbeta neo-2 (ATCCTCATCCTGTCTCTTGA), which amplify a 480-nucleotide fragment including the 5' portion of exon 1 and the 5' end of the neomycin resistance gene. PKA-deficient mice with different mutant combinations of Calpha and Cbeta 1 alleles were generated by intercrossing Calpha +/-Cbeta 1+/- heterozygous mice. When the vaginal plug was detected in the morning, noon of the same day was considered as E0.5 for the timing of embryos. All dissection was performed in M2 medium (Sigma). Genotyping of embryos was performed by PCR analysis using yolk sac DNA.

Skeleton Preparation from Newborn Pups-- After removing skin and viscera, carcasses were fixed overnight in 95% ethanol and stained overnight using 0.015% alcian blue in a solution of 4 parts of 95% ethanol and 1 part of acetic acid. Samples were put back in 95% ethanol for 2-5 h and then incubated in 0.5% KOH for 4-5 days. Skeletons were stained in 0.015% alizarin red, 0.5% KOH and cleared in 0.5% KOH, 20% glycerol for about 2 days. Skeletons were stored and photographed in a 1:1 mixture of glycerol and 95% ethanol.

Histology-- Embryos were fixed overnight in Methacarns (6 parts of methanol, 3 parts of chloroform, and 1 part of acetic acid) at room temperature and embedded in paraffin. Samples were sectioned at 8 µm and stained with hematoxylin and eosin. Sections were viewed under a Nikon microscope and photographed.

Immunohistochemistry and Whole-mount in Situ Hybridization-- Embryos were fixed in 4% paraformaldehyde at 4 °C for 2-4 h, washed in phosphate-buffered saline (PBS), and submerged in 30% sucrose plus PBS overnight at 4 °C. Samples were embedded in O.C.T. compound (Sakura Finetek) and cryosectioned at 20 µm. Sections were washed with PBS and blocked using 10% goat serum (Zymed Laboratories Inc., San Francisco, CA) in PBS with 0.1% Triton X-100. Incubation of primary antibodies was performed at 4 °C in 1% goat serum plus PBS with 0.1% Triton X-100 overnight. Secondary antibody was fluorescein-conjugated goat IgG fraction to mouse IgG (ICN, Aurora, OH). Sections were visualized using a Bio-Rad MRC 600 confocal laser scanning microscope, and images were captured using COSMOS software. The antibodies used in this study are described and referenced in the Developmental Studies Hybridoma Bank data base at the University of Iowa.

Immunohistochemistry for cleaved caspase-3 was performed according to manufacturer's protocol (Cell Signaling Technology, Beverly, MA). The secondary antibody was biotinylated anti-rabbit IgG followed by fluorescein avidin D (Vector Laboratories, Inc., Burlingame, CA). The sections were visualized using a Leica spectral confocal microscope.

RNA in situ hybridization was carried out as described (17) using digoxigenin-labeled probe. Immunological detection was performed using preabsorbed anti-digoxigenin-AP Fab fragments (Roche Molecular Biochemicals) and colored with BM Purple AP substrate (Roche Molecular Biochemicals).

Western Blots and Protein Kinase Activity Assay-- Wild type C57/BL6 embryos at E9.5 were used for dissection of the following three portions of the neural tube: posterior neural tube (thoracic to sacral), anterior neural tube (cervical/brachial), and cranial neural tube. The dissection was performed in PBS, and tissues including the body wall, limb buds, heart, and the brachial arches were removed. Samples from a total of 65 embryos were pooled together and then homogenized in buffer (250 mM sucrose, 20 mM Tris, pH 7.6, 5 mM MgAc, 0.1 mM EDTA, 0.5 mM EGTA, 10 mM dithiothreitol, 1.0% Triton X-100, 10% deoxycholate sodium salt, 2 µg/ml leupeptin, 3 µg/ml aprotinin, 0.2 mg/ml soybean trypsin inhibitor, 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride), sonicated, and centrifuged for 10 min at 12,000 × g at 4 °C. Supernatants were collected, and the protein concentration was measured by Bradford method (Bio-Rad). Forty micrograms of protein were loaded onto individual lanes of a 10% SDS-PAGE and transferred to a nitrocellulose membrane. The blots were stained with 0.2% Ponceau S before blocking overnight in blocking buffer (10 mM Tris-Cl, pH 8.0, 150 mM NaCl, 5% bovine serum albumin, 0.05% Tween 20) and probed with anti-Calpha or anti-Cbeta polyclonal antibodies. The blots were then incubated with horseradish peroxidase secondary antibody and visualized using the Amersham ECL system.

Protein homogenates from the dissected neural tubes were assayed for kinase activity in the presence and absence of cAMP using Kemptide (Sigma) as a substrate as described (18).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reduced PKA Activity Causes Neural Tube Defects Leading to Spina Bifida-- To investigate PKA function during embryonic development, we generated a PKA-deficient mouse with only one functional catalytic subunit allele by crossing the Calpha and Cbeta 1 knockout mice. Calpha and Cbeta , the two catalytic subunit genes of PKA, had been previously disrupted using gene targeting in ES cells in mice. The Calpha knockout disrupts exons 6-8 and eliminates expression of both Calpha 1 and Calpha 2 (15). In these animals, PKA activity was greatly reduced in all tissues except brain, where there was only a 50% decrease of PKA activity because of a compensatory increase of Cbeta proteins. The Cbeta 1 knockout used in these studies is disrupted in exon1 preventing expression of Cbeta 1 but allowing synthesis of Cbeta 2 and Cbeta 3 in brain (13, 16). There was no significant change of PKA activity or apparent compensation of Calpha levels in all tissues examined. Mice with one or two mutant C subunit alleles, either Calpha or Cbeta 1, were born with no apparent embryonic defects (Table I). However, PKA-deficient mice with three mutant C subunit alleles were found to have malformations in their spinal columns (Fig. 1A). The spinal column defects in newborn PKA-deficient pups were located in their thoracic and lumbar regions. The malformed area was not covered by the vertebral arches, but only by skin. Skeleton preparation from the mutant newborn pups revealed that the vertebral arches failed to fuse at the dorsal midline between forelimbs and hindlimbs, whereas all other components of the vertebrae were present with regular ossification (Fig. 1, B and C). The malformation of vertebral arches defines the mutation in PKA-deficient mice as spina bifida. The spine also showed a ventral curvature at the defective region. The defective phenotype was 100% penetrant. The mutant pups, when kept with their parents, were rejected and left out of the litter, and later died probably from starvation. Moreover, all 22 mutant pups obtained were Calpha +/-Cbeta 1-/- with a single functional Calpha allele. None of them were found to have two mutant Calpha alleles and a single functional Cbeta allele. Analysis of embryos from timed mating revealed that the mutant embryos with a single functional Cbeta allele died by embryonic day 14 (E14), indicating a more severe phenotype.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Consequences of successively removing catalytic subunit alleles of PKA in mice


View larger version (68K):
[in this window]
[in a new window]
 
Fig. 1.   Neural tube defects leading to spina bifida in PKA-deficient mice. A, newborn PKA-deficient mouse with spina bifida. The malformation in the spinal column in the PKA-deficient pup (right) is located at the thoracic and lumbar regions (arrow). The mouse at left is a normal littermate control. B and C, dorsal view of skeleton preparation from newborn mice. Bone is stained purple, and cartilage is stained blue. PKA-deficient mouse (C) showing the opening of vertebral arches between forelimbs and hindlimbs (arrow) compared with wild type (B). D and E, neural tube defect (yellow arrows) at the region posterior to the forelimb buds of PKA-deficient embryos at E10.5 (left in both D and E). Approximately 25% of embryos with a single Cbeta allele develop both spinal neural tube defects (yellow arrow) together with exencephaly (red arrow) (left in E). Exencephaly is partially penetrant and only seen in embryos with a single functional Cbeta allele. Wild type embryos are on the right (D and E).

Embryos were examined from E8.5 to E12.5 to ascertain when the spinal column defect in PKA-deficient mice occurred during embryogenesis. The genotypes of embryos were determined by PCR analysis of DNA isolated from visceral yolk sac. Mutant embryos can be first distinguished from their wild type littermates at E9.5 by an expansion of the dorsal neural canal (data not shown). The defect was only observed in the neural tube posterior to the forelimb buds. The anterior spinal cord appeared normal. At E10.5, the neural tube defect became more obvious with varying severity in individual embryos, probably because of embryo to embryo variations in developmental stage. The most severe phenotype was observed as a blister-like bulging of the neural tube along the dorsal midline covering the region of thoracic, lumbar and sacral neural tube (Fig. 1D). The bulging neural tube appeared to be covered by epithelial tissue, which was consistent with the observation of the affected spinal column in the newborn pups. In addition, some of the Calpha -/-Cbeta 1+/- mutants also exhibited exencephaly (open cranial neural tube) (Fig. 1E). As summarized in Table I, all Calpha +/-Cbeta 1-/- embryos had only spinal neural tube defect, whereas approximately one fourth of Calpha -/-Cbeta 1+/- embryos developed exencephaly in addition to the spinal neural tube defect. Exencephaly alone was not observed. As described below, the morphology and the neuronal patterning in the defective spinal neural tube were indistinguishable in embryos of either the Calpha +/-Cbeta 1-/- or Calpha -/-Cbeta 1+/- genotype.

Neural Tube Expansion and Dorsal Root Ganglion Regression in PKA-deficient Embryos-- Histological examination of the developing neural tube was performed in embryos from E9.5 to E12.5. Transverse sections through the thoracic to sacral neural tube of mutant embryos at E9.5 and also some embryos at E10.5 showed a closed neural tube with an expanded alar plate and enlarged lumen (Fig. 2, A and B). The neural tube at the cervical region appeared normal (data not shown). In the longitudinal sections through the dorsal half of the neural tube, the neuroepithelium appeared expanded (Fig. 2, C and D), indicating a possible overproliferation within the dorsal neural tube at this developmental stage. A similar phenotype in the neural tube has been observed in transgenic embryos expressing a dominant negative form of PKA in dorsal aspects of the mouse central nervous system (6).


View larger version (133K):
[in this window]
[in a new window]
 
Fig. 2.   Histological examination of neural tube sections. A and B, transverse sections at the hindlimb level show the expansion of the neural tube in a PKA-deficient embryo (B) compared with the wild type (A) at E10.5. C and D, longitudinal sections through the dorsal half of the neural tube reveal the apparent hyperplasia in the PKA-deficient neuroepithelium (D) compared with the wild type (C) at E10.5. Note the appearance of DRG (arrows) along the PKA-deficient neural tube (D). E and F, transverse sections at the lumbar region of wild type (E) and PKA-deficient embryos (F) at E12.5. Note the dramatic expansion and the abnormal neuroepithelium in the PKA-deficient neural tube and the regression of DRG (F). DRG in wild type is shown in E (arrow).

We examined bromodeoxyuridine incorporation in the spinal cord of mutant embryos to identify cells that have divided. The average number of labeled cells in sections of the affected neural tube of E9.5 and E10.5 embryos at hindlimb level was compared with that in corresponding sections of wild type controls. The result revealed no difference between the mutants and their controls in the number of proliferating cells in the whole transverse sections of neural tube (data not shown), suggesting that the aberrant morphology is not caused by overproliferation.

In embryos older than E10.5, the expansion of the neural canal increased dramatically. Transverse sections showed that the lumen was significantly enlarged and the neuroepithelium contained a higher cell density compared with wild type control (Fig. 2, E and F). In addition to the change in neural tube morphology, dorsal root ganglia (DRG) were also affected. DRG were formed in the mutant E10.5 embryos, even though they appeared disorganized (Fig. 2D), but they regressed at E12.5, suggesting that PKA activity might be required for DRG maintenance. The loss of DRG cells could indicate a possible abnormal cell death in neural crest cell derivatives, which might also occur in the neural tube.

To test the possibility of increasing apoptosis in the affected neuroepithelium and neural crest, immunohistochemistry was performed to detect activated caspase-3 in the developing neural tube of E10.5 embryos. Caspase-3 is one of the key executioner caspases of cell death and the activated form of caspase-3 is usually only found in cells undergoing apoptosis. In the neural tube of PKA-deficient embryos, apoptotic cells were frequently observed compared with the rare occurrence of apoptotic cells in wild type embryos (Fig. 3). Most of the apoptotic cells in the mutant were located in dorsal and/or lateral regions of the neural tube. In addition to the neural tube, a more significant increase in cell death was also detected in DRG adjacent to the affected neural tube, but not in DRG at other axial levels of PKA-deficient embryos (Fig. 3C). Despite the observed increase in apoptosis, the total number of apoptotic cells observed in the defective neuroepithelium was still very small and could easily be overcome by the large number of dividing cells in the neural tube. Therefore, the increased cell death is unlikely to be a major determinant of the neuroepithelial abnormality. The more significant increase in DRG cell death may account for the regression of these structures observed in mutant embryos.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 3.   Apoptotic cell death in the neural tube and DRG of E10.5 embryos. A-C, clusters of apoptotic cells were frequently observed in the neural tube (yellow arrow) and DRG (red arrow) in PKA-deficient embryos. D, in wild type sections, apoptotic cells were rare, but they could be detected occasionally in the neural tube (yellow arrow) and in DRG (not in the section shown here).

Differential Levels of the Catalytic Subunits of PKA in Axial Structures-- One interesting phenomenon in our study is that the neural tube defects were only detected posterior to the forelimb buds of PKA-deficient embryos. What makes the posterior part of the spinal neural tube more sensitive to the decrease in PKA activity compared with other regions? One possible reason could be that the expression of the catalytic subunits of PKA are differentially distributed along the anterior-posterior regions of the neural tube, causing PKA activity in some region to be closer to the cellular threshold below which mutations become apparent. The observed mutant phenotype might suggest a lower PKA activity at thoracic to sacral regions. To test this, we dissected the axial structures including the neural tube, paraxial mesoderm, and the attached ectoderm from E9.5 wild type C57/BL6 embryos. The axial structure was collected in three parts: cranial neural tube, anterior (cervical/brachial) neural tube, and posterior (thoracic to sacral) neural tube. Western blots using protein extracts were analyzed to quantitate the expression of C subunits. The analysis demonstrated that there was slightly less C subunit expression in the posterior neural tube compared with the anterior neural tube (Fig. 4A), and this correlated with a 20% decrease in PKA activity in the posterior compared with anterior regions (Fig. 4B). Both the results from Western blot and kinase assay indicate a modest difference in overall expression of catalytic subunits of PKA, but we believe that this is unlikely to explain the dramatic differences we see in morphology and gene expression (see below) in the affected posterior region.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 4.   Differential levels of catalytic subunits of PKA along the anterior-posterior neural tube. A, Western blots showing levels of catalytic subunits in cranial, anterior, and posterior neural tube of E9.5 wild type embryos. Anti-Calpha antibody detects both isoforms of Calpha and Cbeta . Calpha 1and Cbeta 1 have similar molecular weights. Anti-Cbeta antibody detects Cbeta isoforms only. B, PKA activity in the dissected neural tube. The basal (-cAMP) and the total activable (+cAMP) PKA activity are shown after subtracting nonspecific background.

The Western analysis also demonstrated that both Calpha and Cbeta genes were expressed as a single protein isoform, Calpha 1 and Cbeta 1, respectively, in the axial tissues of mouse embryos at E9.5. Calpha 2, the testis-specific isoform in adult mice, was not detectable at this developmental stage, and the brain-specific isoforms, Cbeta 2 and Cbeta 3, were also absent.

Ectopic Expression of Shh Signaling and Altered Neuronal Identity in the Neural Tube of PKA-deficient Embryos-- The PKA pathway has been implicated as a negative regulator of Sonic hedgehog signaling in development, and Shh signaling is a major organizer for dorsal/ventral patterning in the neural tube. Therefore, we examined the manifestations of Shh signaling and the specification of neuronal identity in the neural tube of PKA-deficient embryos at E10.5.

Shh is sufficient for the induction of floor plate cells (19), which express Hnf3beta and Shh itself. In PKA-deficient embryos, the expression of both Shh and Hnf3beta was expanded dorsally (Fig. 5, B and F). Shh expression was detected in the ventral half of the neural tube at levels similar to a normal floor plate. The expression domain of Hnf3beta was also greatly expanded in the ventral neural tube, albeit at levels lower than those found at the ventral midline (Fig. 5F). Cells with lower Hnf3beta expression did not display typical floor plate morphology, i.e. a single layer with basal nuclei. Interestingly, the dorsal expansion of Shh and Hnf3beta expression was correlated only with the abnormal morphology in the affected neural tube. In the cervical neural tube, Shh and Hnf3beta were expressed normally (Fig. 5, C and D; data not shown). The same localized effect was also observed with the whole mount in situ hybridization of PKA-deficient embryos at E9.5, which demonstrated that the ectopic expression of Hnf3beta was localized to the region posterior to the forelimb buds (Fig. 5G).


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 5.   Dorsalized expression of Shh and Hnf3beta in the affected neural tube at the posterior region of PKA-deficient mice, but not in the anterior neural tube. A-F, immunohistochemistry on neural tube sections of E10.5 wild type (A, C, and E) and PKA-deficient (B, D, and F) embryos. A and B, expression of Shh at the lumbar (posterior) region. C and D, expression of Shh at the cervical (anterior) region. E and F, expression of Hnf3beta at the lumbar (posterior) region. G, whole-mount in situ hybridization of E9.5 embryos showing the expression of Hnf3beta . Notice the dorsalized expression in the PKA-deficient embryo (left) is localized in the neural tube posterior to the forelimb buds. H, a drawing of a mouse embryo showing the regions of anterior and posterior neural tube.

Shh is required for the induction of motor neurons and adjacent interneuron progenitors in the ventral neural tube, which is mediated by regulating the expression of several homeodomain proteins (20-25). The dorsalized expression of Shh in PKA-deficient embryos may lead to an altered patterning of neuronal identity in the neural tube. We analyzed the pattern of ventral neuronal progenitors in the PKA-deficient neural tube by focusing on the expression of two homeodomain proteins, Pax6 and Nkx2.2. Shh signaling represses the expression of Pax6, which, in turn, represses the expression of Nkx2.2 in V3 interneuron progenitor cells at the region dorsolateral to the floor plate (24, 25) (Fig. 6, A and C). In the affected neural tube of PKA-deficient embryos, the expression of Pax6 was repressed in most of the neural tube, with some dorsal Pax6 expressing cells remaining (Fig. 6B). Consistent with this, expression of Nkx2.2 was dorsally expanded with the dorsal boundary extending into the medial/dorsal ventricular zone of the neural tube (Fig. 6D). The dorsalized expression of Pax6 could be a consequence of ectopic activation of the Shh response in the affected neural tube. These results indicate a change of neuronal identity in the affected neural tube that leads to a ventralized neural tube, which we confirmed by examining the induction of motor neurons. Motor neuron progenitor cells, which are located immediately dorsal to V3 interneuron progenitors, express low levels of Pax6 but not Nkx2.2. The post-mitotic motor neurons were detected by the expression of the homeodomain proteins Islet1/2, which mark DRG cells and differentiated motor neurons (24). In wild type mice, Islet1/2-expressing motor neurons are located immediately dorsal to V3 interneurons in ventrolateral regions adjacent to the ventricular zone of the neural tube (Fig. 6G). In PKA-deficient mice, Islet1/2-labeled motor neurons were dorsally expanded into the intermediate zone, consistent with the Nkx2.2 expansion and Pax6 repression (Fig. 6H).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Ventralized neuronal identity in the affected neural tube. Immunohistochemistry on sections of lumbar neural tube of E10.5 wild type (A, C, E, and G) and PKA-deficient (B, D, F, and H) embryos showing the expression domains of Pax6 (A and B), Nkx2.2 (C and D), Pax7 (E and F), and Islet1/2 (G and H). Notice the expression of Pax7 in the somites remains normal in PKA-deficient mice (arrows in E and F).

Because of the appearance of ventral neuronal progenitors in the dorsal neural tube, we next examined the fate of dorsal cell types in the affected neural tube. Pax7, one of the class I homeodomain proteins (26), is normally expressed in the dorsal half of the neural tube and repressed by Shh in the ventral neural tube (Fig. 6E) (23). The ventral limit of Pax7 expression defines the ventral boundary of the dorsal neuron progenitors (26). In the affected neural tube of PKA-deficient embryos, there was no detectable Pax7 expression (Fig. 6F), indicating a significant loss of dorsal cell types.

Consistent with the observed ectopic expression of Shh and Hnf3beta , the altered distribution of the neuronal cell types only occurred in the neural tube posterior to the forelimb buds in PKA-deficient embryos. In the cervical region of the neural tube, the results of marker analysis appeared normal (data not shown). These observations indicate that the spinal neural tube is not a homogeneous structure and suggest differences in signal transduction systems along the anterior-posterior axis of the neural tube.

Complete C-deficient Embryos Survive to Gastrulation Stage-- In our study of PKA-deficient mice, we also produced complete C-deficient embryos in which all four C alleles were mutated. From the mating between Calpha +/-Cbeta 1+/- mice, by ratio, 1 of 16 embryos will be completely C-deficient. We examined embryos at stages E8.5 to E10.5 from timed mating of Calpha +/-Cbeta 1+/- mice, and discovered 20 complete C-deficient embryos (Calpha -/-Cbeta 1-/-) from 329 implantations (1/16). The expected ratio in production of complete C-deficient embryos indicated that defects in these embryos did not prevent implantation, although the complete C-deficient embryos were all in various stages of resorption. It is unlikely that maternal PKA activity is sufficient to sustain development up to the gastrulation stage. Either PKA activity is not absolutely required for very early development or other related kinases are able to partially compensate. For instance, PrKX, an X chromosome-linked kinase related to catalytic subunits of PKA, has been shown to interact with RI subunits in a cAMP-dependent manner (27).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

PKA-deficient mice were bred by crossing Calpha and Cbeta 1 heterozygotes to obtain embryos with only one functional C allele. Based on previous characterization of the Calpha and Cbeta 1 null mice, we might expect some compensatory increase in C expression from the remaining functional allele, but this is insufficient to maintain PKA activity. The decreased PKA activity leads to the appearance of axially localized neural tube defects in the thoracic to sacral regions of the neural tube and may also include exencephaly if both Calpha alleles are mutated and only a single functional Cbeta allele remains. The affected neural tube in PKA-deficient mice is closed but expanded with an abnormal neuroepithelium. The vertebral arches fail to fuse in the malformed region of the spinal cord. Decreasing PKA activity results in dorsal expansion of Shh signaling and ventralization of the pattern of neuronal identity in the defective neural tube. An increase in apoptotic cell death in the abnormal neuroepithelium and dorsal root ganglia suggests that PKA is also involved in neuronal cell survival during development.

Neural Tube Defects in PKA-deficient Mice-- NTDs are common congenital abnormalities in humans with an occurrence of 1 in ~1000 births. The etiology of neural tube defects is multifactorial, and both genetic and environmental factors are involved. Mouse models have been used to study the embryonic mechanisms and genetic basis of neural tube defects (28, 29), and these studies have uncovered a heterogeneous collection of genes that may be involved.

More than 60 mouse mutants have been reported to exhibit neural tube defects (29, 30). However, most of them also have syndromes involving other tissues that cause early embryonic lethality. In these mutants, NTDs are likely to be secondary to primary defects in other developmental systems. In a few mutants that survive to later stages of embryogenesis, mutations are likely to be more specific to neurulation and cause defects in the neural tube directly. For example, Splotch (Sp) mice resulting from mutation of the Pax3 gene develop neural tube defects with varying penetrance during neurulation and die by E13 because of cardiac defects (31). Targeted disruption of p53 (coding for a tumor suppressor) (32, 33), MARCKS (a substrate of protein kinase C) (34), or ApoB (a transporter protein) (35) genes all lead to exencephaly in 20-30% of embryos. These mutants can survive to birth and are not severely defective in other developmental systems except for the neural tube defects.

The PKA-deficient mice examined in this study exhibit neural tube defects without other apparent malformation, suggesting that PKA can play a specific role in neural tube formation. In contrast to the low penetrance of NTDs in other mutants, PKA-deficient mice develop spinal neural tube defects with 100% penetrance. Some mice that retain one functional Calpha allele are born alive without other apparent malformations except spina bifida at their thoracic and lumbar regions. Mice that retain one functional Cbeta allele display a more profound developmental abnormality that includes exencephaly in ~25% of embryos as well as the characteristic NTD described above for the mice with a single Calpha allele.

In many mouse mutations, spina bifida presents as a severe form in which both vertebral arches and the neural tube fail to close. Other less severe forms of spina bifida are characterized by normal closure and development of the neural tube but open vertebral arches (30). In general, the more severe form is a result of malformation caused primarily by a neural defect, whereas the other forms of spina bifida may be caused by mesodermal defects. The anatomy of a closed but defective neural tube in PKA-deficient mice appears to represent a novel category. The abnormal neuroepithelium and the altered differentiation of neuronal precursors in the neural tube indicate that the primary defect in PKA-deficient embryos is affecting the developing neuroepithelium. We propose that the dramatic expansion of the closed neural tube causes failure of the vertebral arches to fuse in PKA-deficient mice. These special features make the PKA-deficient mice an interesting model for the study of neural tube defects.

Increased Apoptotic Cell Death in the Affected Neural Tube of PKA-deficient Mice-- Apoptosis is a highly regulated cellular process that is essential for embryonic development. The PKA signaling pathway has been implicated in the regulation of apoptosis by modulating the levels and/or activities of Bcl-2 and related proteins, and this may depend on the isoforms of PKA expressed, their subcellular localization, and availability of specific substrates (36). Studies have suggested that PKA action is at a site upstream of caspase-3 (37, 38). Therefore, we used activated caspase-3 as a marker for apoptotic cells and observed an increased incidence of cell death in the neural tube and DRG in PKA-deficient mice. This suggests that PKA activity serves as an anti-apoptotic signal in the developing neural tube. Although apoptosis increases in the PKA-deficient neural tube, this is unlikely to be the primary mechanism leading to the neural tube defect and is more likely the result of misspecification of neuronal cell types caused by induction of Shh signaling earlier in development.

Dorsalized Shh Signaling in PKA-deficient Neural Tube-- Shh is a notochord and floor plate-derived signal required to pattern the ventral neural tube and induce the formation of motor neurons and ventral interneurons (21-23, 39). The induction of different cell types in the ventral neural tube is controlled in a concentration-dependent manner. Cells positioned in progressively more ventral regions are exposed to higher Shh concentrations, and this triggers differentiation into distinct cell types (21, 24, 25).

Shh signal response can be negatively regulated by PKA. Either too much or too little PKA activity can result in changes in gene expression and tissue patterning by modulating the Shh signaling pathway (5-8). In the developing neural tube, expression of a dominant-negative regulatory subunit of PKA in dorsal aspects of the central nervous system activated Shh signaling in the region of the dorsal midbrain and mid/hindbrain junction. This resulted in the dorsal activation of Hnf3beta and Shh, aberrant motor neuron induction, and ectopic expression of Patched (Ptc) and Gli1 (6). In our PKA-deficient mice, we have observed a similar effect resulting in dorsal expansion of Shh-dependent cell types and ventralization of the neural tube. This dorsal expansion of Shh-dependent response includes Shh itself, which can be found in a significantly expanded domain. Therefore, we cannot distinguish between a cell autonomous or nonautonomous mechanism explaining the expansion of the Shh-dependent cell types. The increased Shh response in ventral plate cells induces them to adopt a more ventral fate, including V3 interneurons and motor neurons. Subsequently, cells positioned in the dorsal neural tube are induced to differentiate into ventral cell types. Because the expression of the dorsal marker Pax7 is undetectable, it is likely that the dorsal cell progenitors are never induced. Despite the marked ventralization of neuronal cell types, the relative position of different gene expression domains remained, suggesting that the mutually repressive interaction between class I and class II homeoproteins (26) is maintained in the PKA-deficient neural tube. Moreover, not all of the cells that express Hnf3beta in the ventral neural tube display the floor plate morphology. A possible explanation is that the floor plate cells are induced early in development and cells in the ventral neural tube of PKA-deficient mice are induced to express Hnf3beta at later stages, when they are no longer capable of adopting the floor plate cell fate. This is in contrast to what has been observed in Patched mutants, in which all cells expressing Shh and Hnf3beta are floor plate cell-like (40).

The dorsalized Shh signaling was only observed in the affected neural tube at the thoracic to sacral regions. In the head and cervical regions that showed wild type morphology, the distribution of Shh signaling and pattern of the neuronal cell types remained normal. The strong correlation between the dorsalized Shh signaling and the neural tube defect suggested that the ectopic expression of Shh itself might be responsible for the neural tube defect. Alternatively, the PKA deficiency may elicit downstream signaling events that lead to changes in gene expression in a completely Shh-independent manner. This could be explored further by producing PKA-deficient embryos on a Shh null background.

Studies have suggested several downstream components in the Shh pathway as potential targets for PKA phosphorylation. For instance, Smoothened (Smo) contains a cluster of putative PKA sites in its C-terminal cytoplasmic domain and PKA could target Smo for degradation by direct phosphorylation (41). Studies have also shown that Gli2 and Gli3, two major mediators of Shh signals, can be phosphorylated upon PKA stimulation (42). Phosphorylation of Gli3 has been shown to promote its proteolytic processing to generate a repressor form of the transcription factor (42). A recent study of Shh and Gli3 double mutants showed that a null mutation in Gli3 can partially rescue the mutant phenotypes of a Shh knockout embryo (43). However, it is interesting to note that this rescue of ventral cell fates was dependent on position along the rostral-caudal axis. Motor neurons were substantially rescued only in the lumbar region, and the rescue of V0 and V1 interneurons was also much greater in this region. Because PKA activity regulates the formation of Gli3 repressor, it seems likely that PKA deficiency is mimicking the Gli3 knockout by preventing proteolytic processing to the repressor form. Normally, Gli3 might function as a weak activator of Shh signaling in the ventral neural tube, and studies have shown that Gli3 is expressed throughout the neural plate (44, 45). It is possible that PKA phosphorylates Gli3, thus promoting the conversion of Gli3 from a weak activator to a repressor in the dorsal neural tube, whereas this conversion is blocked by Shh signaling in the ventral neural tube. Therefore, in PKA-deficient mice, the level of the repressor form of Gli3 could be reduced in the dorsal neural tube, resulting in changes in neuronal specification that mimics Shh signaling. However, reducing the level of Gli3 repressor alone is unlikely to be sufficient to cause a defect in the neural tube because mice lacking Gli3 show no ectopic activation of Shh signaling and no discernible phenotype in the spinal cord (46, 47). Perhaps, other factors that interact with Shh signaling, such as BMP and Wnt (48), are also modulated by PKA activity. Although endogenous processing of Gli2 has not been demonstrated, it has been shown that an N terminus-deleted form of Gli2, but not full-length Gli2, can induce Shh-dependent cell types in the dorsal neural tube when ectopically expressed (49). It is possible that PKA deficiency may lead to an increase in Gli2 activator levels.

The increased Shh signal response seen in the PKA-deficient mice is consistent with previous work in Drosophila, zebrafish, and mice. However, the localized effect in a discrete region of the neural tube suggests that PKA-dependent modulation of Shh signaling differs qualitatively along the posterior to anterior axis. Our dissection of the neural tube does not show significant changes in the expression of PKA catalytic subunits from posterior to anterior regions, suggesting that the sensitivity of the thoracic to sacral region is not the result of differential levels of PKA activity. Although the large changes in PKA activity produced in PKA-deficient mice lead to developmental defects, it is likely that smaller changes in PKA activity are normally regulating neural precursor differentiation during development. This suggests that as yet unknown factors may be interacting with receptors to regulate intracellular cAMP and modulate developmental signals such as Shh.

    ACKNOWLEDGEMENTS

We thank Paul Amieux for suggestions on the manuscript and Susan Taylor for the Calpha antibody. We also thank the W. M. Keck Center for Advanced Studies in Neural Signaling for the use of confocal imaging systems.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant GM32875.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 206-616-4237; Fax: 206-616-4230; E-mail: mcknight@u.washington.edu.

Published, JBC Papers in Press, March 8, 2002, DOI 10.1074/jbc.M111412200

2 P. S. Amieux, D. Howe, H. Knickerbocker, D. C. Lee, T. Su, R. L. Idzerda, and G. S. McKnight, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: PKA, protein kinase A; C, catalytic; R, regulatory; NTD, neural tube defect; E, embryonic day; PBS, phosphate-buffered saline; DRG, dorsal root ganglia.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Bornslaeger, E. A., Mattei, P., and Schultz, R. M. (1986) Dev. Biol. 114, 453-462[CrossRef][Medline] [Order article via Infotrieve]
2. Matten, W., Daar, I., and Vande Woude, G. F. (1994) Mol. Cell. Biol. 14, 4419-4426[Abstract/Free Full Text]
3. Poueymirou, W. T., and Schultz, R. M. (1989) Dev. Biol. 133, 588-599[CrossRef][Medline] [Order article via Infotrieve]
4. Perrimon, N. (1995) Cell 80, 517-520[CrossRef][Medline] [Order article via Infotrieve]
5. Hammerschmidt, M., Bitgood, M. J., and McMahon, A. P. (1996) Genes Dev. 10, 647-658[Abstract/Free Full Text]
6. Epstein, D. J., Marti, E., Scott, M. P., and McMahon, A. P. (1996) Development 122, 2885-2894[Abstract]
7. Fan, C. M., Porter, J. A., Chiang, C., Chang, D. T., Beachy, P. A., and Tessier-Lavigne, M. (1995) Cell 81, 457-465[CrossRef][Medline] [Order article via Infotrieve]
8. Hynes, M., Porter, J. A., Chiang, C., Chang, D., Tessier-Lavigne, M., Beachy, P. A., and Rosenthal, A. (1995) Neuron 15, 35-44[CrossRef][Medline] [Order article via Infotrieve]
9. Goodrich, L. V., and Scott, M. P. (1998) Neuron 21, 1243-1257[CrossRef][Medline] [Order article via Infotrieve]
10. Ingham, P. W. (1998) EMBO J. 17, 3505-3511[CrossRef][Medline] [Order article via Infotrieve]
11. McKnight, G. S. (1991) Curr. Opin. Cell Biol. 3, 213-217[CrossRef][Medline] [Order article via Infotrieve]
12. Desseyn, J. L., Burton, K. A., and McKnight, G. S. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 6433-6438[Abstract/Free Full Text]
13. Guthrie, C. R., Skalhegg, B. S., and McKnight, G. S. (1997) J. Biol. Chem. 272, 29560-29565[Abstract/Free Full Text]
14. Cadd, G., and McKnight, G. S. (1989) Neuron 3, 71-79[CrossRef][Medline] [Order article via Infotrieve]
15. Skalhegg, B. S., Huang, Y., Su, T., Idzerda, R. L., McKnight, G. S., and Burton, K. A. (2002) Mol. Endocrinol. 16, 630-639[Abstract/Free Full Text]
16. Qi, M., Zhuo, M., Skalhegg, B. S., Brandon, E. P., Kandel, E. R., McKnight, G. S., and Idzerda, R. L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1571-1576[Abstract/Free Full Text]
17. Spector, D., Goldman, R. D., and Leinwand, L. A. (1998) Cells: A Laboratory Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
18. Clegg, C. H., Correll, L. A., Cadd, G. G., and McKnight, G. S. (1987) J. Biol. Chem. 262, 13111-13119[Abstract/Free Full Text]
19. Roelink, H., Augsburger, A., Heemskerk, J., Korzh, V., Norlin, S., Ruiz i Altaba, A., Tanabe, Y., Placzek, M., Edlund, T., and Jessell, T. M. (1994) Cell 76, 761-775[CrossRef][Medline] [Order article via Infotrieve]
20. Marti, E., Bumcrot, D. A., Takada, R., and McMahon, A. P. (1995) Nature 375, 322-325[CrossRef][Medline] [Order article via Infotrieve]
21. Roelink, H., Porter, J. A., Chiang, C., Tanabe, Y., Chang, D. T., Beachy, P. A., and Jessell, T. M. (1995) Cell 81, 445-455[CrossRef][Medline] [Order article via Infotrieve]
22. Chiang, C., Litingtung, Y., Lee, E., Young, K. E., Corden, J. L., Westphal, H., and Beachy, P. A. (1996) Nature 383, 407-413[CrossRef][Medline] [Order article via Infotrieve]
23. Ericson, J., Morton, S., Kawakami, A., Roelink, H., and Jessell, T. M. (1996) Cell 87, 661-673[CrossRef][Medline] [Order article via Infotrieve]
24. Ericson, J., Rashbass, P., Schedl, A., Brenner-Morton, S., Kawakami, A., van Heyningen, V., Jessell, T. M., and Briscoe, J. (1997) Cell 90, 169-180[CrossRef][Medline] [Order article via Infotrieve]
25. Briscoe, J., Sussel, L., Serup, P., Hartigan-O'Connor, D., Jessell, T. M., Rubenstein, J. L., and Ericson, J. (1999) Nature 398, 622-627[CrossRef][Medline] [Order article via Infotrieve]
26. Briscoe, J., Pierani, A., Jessell, T. M., and Ericson, J. (2000) Cell 101, 435-445[CrossRef][Medline] [Order article via Infotrieve]
27. Zimmermann, B., Chiorini, J. A., Ma, Y., Kotin, R. M., and Herberg, F. W. (1999) J. Biol. Chem. 274, 5370-5378[Abstract/Free Full Text]
28. Copp, A. J., and Bernfield, M. (1994) Curr. Opin. Pediatr. 6, 624-631[Medline] [Order article via Infotrieve]
29. Juriloff, D. M., and Harris, M. J. (2000) Hum. Mol. Genet. 9, 993-1000[Abstract/Free Full Text]
30. Harris, M. J., and Juriloff, D. M. (1999) Teratology 60, 292-305[CrossRef][Medline] [Order article via Infotrieve]
31. Franz, T. (1993) Anat. Embryol. 187, 371-377[Medline] [Order article via Infotrieve]
32. Armstrong, J. F., Kaufman, M. H., Harrison, D. J., and Clarke, A. R. (1995) Curr. Biol. 5, 931-936[CrossRef][Medline] [Order article via Infotrieve]
33. Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T., and Jacks, T. (1995) Nat. Genet. 10, 175-180[CrossRef][Medline] [Order article via Infotrieve]
34. Stumpo, D. J., Bock, C. B., Tuttle, J. S., and Blackshear, P. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 944-948[Abstract/Free Full Text]
35. Homanics, G. E., Maeda, N., Traber, M. G., Kayden, H. J., Dehart, D. B., and Sulik, K. K. (1995) Teratology 51, 1-10[CrossRef][Medline] [Order article via Infotrieve]
36. Cross, T. G., Scheel-Toellner, D., Henriquez, N. V., Deacon, E., Salmon, M., and Lord, J. M. (2000) Exp. Cell Res. 256, 34-41[CrossRef][Medline] [Order article via Infotrieve]
37. Parvathenani, L. K., Buescher, E. S., Chacon-Cruz, E., and Beebe, S. J. (1998) J. Biol. Chem. 273, 6736-6743[Abstract/Free Full Text]
38. Orlov, S. N., Thorin-Trescases, N., Dulin, N. O., Dam, T. V., Fortuno, M. A., Tremblay, J., and Hamet, P. (1999) Cell Death Differ. 6, 661-672[CrossRef][Medline] [Order article via Infotrieve]
39. Marti, E., Takada, R., Bumcrot, D. A., Sasaki, H., and McMahon, A. P. (1995) Development 121, 2537-2547[Abstract]
40. Goodrich, L. V., Milenkovic, L., Higgins, K. M., and Scott, M. P. (1997) Science 277, 1109-1113[Abstract/Free Full Text]
41. Alcedo, J., Zou, Y., and Noll, M. (2000) Mol. Cell 6, 457-465[CrossRef][Medline] [Order article via Infotrieve]
42. Wang, B., Fallon, J. F., and Beachy, P. A. (2000) Cell 100, 423-434[CrossRef][Medline] [Order article via Infotrieve]
43. Litingtung, Y., and Chiang, C. (2000) Nat. Neurosci. 3, 979-985[CrossRef][Medline] [Order article via Infotrieve]
44. Ruiz i Altaba, A. (1998) Development 125, 2203-2212[Abstract]
45. Hui, C. C., Slusarski, D., Platt, K. A., Holmgren, R., and Joyner, A. L. (1994) Dev. Biol. 162, 402-413[CrossRef][Medline] [Order article via Infotrieve]
46. Hui, C. C., and Joyner, A. L. (1993) Nat. Genet. 3, 241-246[CrossRef][Medline] [Order article via Infotrieve]
47. Theil, T., Alvarez-Bolado, G., Walter, A., and Ruther, U. (1999) Development 126, 3561-3571[Abstract]
48. Roelink, H. (1996) Curr. Opin. Neurobiol. 6, 33-40[CrossRef][Medline] [Order article via Infotrieve]
49. Sasaki, H., Nishizaki, Y., Hui, C., Nakafuku, M., and Kondoh, H. (1999) Development 126, 3915-3924[Abstract]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea